INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 281 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,575,742 | -18.0% | 87,843 | -0.4% | 0.39% | -16.5% |
| Q2 2023 | $5,583,368 | +13.2% | 88,177 | -3.2% | 0.47% | +8.8% |
| Q1 2023 | $4,932,849 | +1.1% | 91,096 | -1.2% | 0.43% | -3.2% |
| Q4 2022 | $4,877,689 | -5.0% | 92,171 | +2.4% | 0.44% | -32.7% |
| Q3 2022 | $5,137,000 | +0.2% | 89,994 | +0.2% | 0.66% | +35.8% |
| Q2 2022 | $5,128,000 | -7.5% | 89,844 | -0.8% | 0.49% | -22.5% |
| Q1 2022 | $5,542,000 | +18.9% | 90,544 | +1.7% | 0.63% | +15.9% |
| Q4 2021 | $4,661,000 | – | 89,051 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |